Washington University School of Medicine

Digital Commons@Becker
Open Access Publications
2014

Endothelial cells use dynamic actin to facilitate lymphocyte
transendothelial migration and maintain the monolayer barrier
Olivia L. Mooren
Washington University School of Medicine in St. Louis

Jinmei Li
Washington University School of Medicine in St. Louis

Julie Nawas
Washington University School of Medicine in St. Louis

John A. Cooper
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs

Recommended Citation
Mooren, Olivia L.; Li, Jinmei; Nawas, Julie; and Cooper, John A., ,"Endothelial cells use dynamic actin to
facilitate lymphocyte transendothelial migration and maintain the monolayer barrier." Molecular Biology of
the Cell. 25,25. . (2014).
https://digitalcommons.wustl.edu/open_access_pubs/8239

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been
accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker.
For more information, please contact vanam@wustl.edu.

MBoC | ARTICLE

Endothelial cells use dynamic actin to facilitate
lymphocyte transendothelial migration and
maintain the monolayer barrier
Olivia L. Mooren, Jinmei Li, Julie Nawas, and John A. Cooper
Department of Cell Biology and Physiology, Washington University, St. Louis, MO 63110

ABSTRACT The vascular endothelium is a highly dynamic structure, and the integrity of its
barrier function is tightly regulated. Normally impenetrable to cells, the endothelium actively
assists lymphocytes to exit the bloodstream during inflammation. The actin cytoskeleton of
the endothelial cell (EC) is known to facilitate transmigration, but the cellular and molecular
mechanisms are not well understood. Here we report that actin assembly in the EC, induced
by Arp2/3 complex under control of WAVE2, is important for several steps in the process of
transmigration. To begin transmigration, ECs deploy actin-based membrane protrusions that
create a cup-shaped docking structure for the lymphocyte. We found that docking structure
formation involves the localization and activation of Arp2/3 complex by WAVE2. The next
step in transmigration is creation of a migratory pore, and we found that endothelial WAVE2
is needed for lymphocytes to follow a transcellular route through an EC. Later, ECs use actinbased protrusions to close the gap behind the lymphocyte, which we discovered is also
driven by WAVE2. Finally, we found that ECs in resting endothelial monolayers use lamellipodial protrusions dependent on WAVE2 to form and maintain contacts and junctions between
cells.
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INTRODUCTION
Endothelial cells (ECs) have critical roles in the immune and vascular
systems. First, they establish and maintain the barrier between the
blood stream and the underlying tissues. Second, they facilitate the
migration of leukocytes from the blood into the tissue. Both functions are highly dynamic and regulated. During inflammation, the
barrier opens in a regulated manner to allow for the passage of fluids, cytokines, and leukocytes. Dysfunction of the endothelial barrier
is a prominent component of many disease states, including atherosclerosis, chronic inflammation, and diabetes (Weber et al., 2007;
Dejana et al., 2008; Bakker et al., 2009; Kumar et al., 2009; Sima
et al., 2009; Rigor et al., 2013).
This article was published online ahead of print in MBoC in Press (http://www
.molbiolcell.org/cgi/doi/10.1091/mbc.E14-05-0976) on October 29, 2014.
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Transendothelial migration (TEM), or diapedesis, is the process
by which leukocytes cross from the bloodstream into the underlying
tissue. ECs actively participate in this process, interacting with the
migrating leukocytes in a complex network of cross-signaling between the cells (Wittchen, 2009; Nourshargh et al., 2010). Signaling
networks in both cells orchestrate complex dynamic changes in the
actin cytoskeleton (Barreiro et al., 2004; Nourshargh et al., 2010),
which control the shape of the cells and generate the forces that
move the leukocyte across the endothelium. The molecular mechanisms for movement by leukocytes have been relatively well studied, but much less is known about the mechanisms by which ECs
enable and promote leukocyte transmigration.
The first step in TEM is formation of a protrusive docking structure on the surface of the EC, which cups the leukocytes. The second step is formation of a transmigratory pore, either within one EC
(the “transcellular” route) or between two ECs (the “paracellular”
route). The final step is closure of the pore after the leukocytes completely transits across the monolayer.
For the paracellular migration route, leukocytes bind to cell junction proteins, such as PECAM, CD99, and JAMs (Muller et al., 1993;
Ostermann et al., 2002; Schenkel et al., 2002; Bradfield et al., 2007;
Lou et al., 2007; Sircar et al., 2007; Weber et al., 2007), and they
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move through loosened cell–cell junctions. In the transcellular migration route, leukocytes pass through a transcellular channel created by the EC. Transcellular migration involves integrin-based interactions between the leukocyte and the EC, along with junctional
proteins between ECs, which redistribute during transmigration
(Carman et al., 2007; Carman and Springer, 2008; Mamdouh et al.,
2009).
Rho GTPases are critical components of the EC signaling pathways that control cell junctions (Aghajanian et al., 2008; Wittchen,
2009; Daniel and van Buul, 2013). Signals are generated by soluble inflammatory mediators, such as tumor necrosis factor α
(TNFα), and by cell-surface adhesion molecules, such as intercellular adhesion molecule 1 (ICAM-1; Stolpen et al., 1986; Clark
et al., 2007; Muller, 2009). These primary signals activate Rac1 and
RhoA in the EC, leading to controlled perturbations in the monolayer (Wojciak-Stothard et al., 1998; Wojciak-Stothard and Ridley,
2002; van Wetering et al., 2002; Nwariaku et al., 2003) and actions
that facilitate leukocyte transmigration (van Wetering et al., 2003;
Wittchen, 2009; Daniel and van Buul, 2013). Rac1 and RhoG promote formation of the actin-based, cup-shaped structure that
docks the transmigrating leukocyte (van Buul et al., 2007; van Rijssel et al., 2012) and also coordinates downstream signaling. Cortactin in endothelial cells has been shown to play a critical role in
many steps during transmigration (Tilghman and Hoover, 2002;
Yang et al., 2006a,b). However, nothing is known about other
Arp2/3 complex regulators downstream of Rac, and little is known
about the how Arp2/3 complex contributes to the various steps
during transmigration.
Martinelli et al. (2013) described roles for Rac1 and Arp2/3 complex in pore closure after transmigration of T-lymphocytes. They
found that ECs use directional lamellipodial protrusions to close
lymphocyte transmigration pores. They concluded that Rac1 activation promoted the formation of these lamellipodia, based on effects
of the Rac1 inhibitor NSC23766 and by overexpression of dominantnegative Rac1. They also used an inhibitor of Arp2/3 complex, CK666, to demonstrate that these lamellipodia depended on the activity of Arp2/3 complex.
Rac1 has several downstream effectors other than Arp2/3 complex, and a number of proteins are able to recruit and activate
Arp2/3 complex; therefore we chose to focus on the role of the
specific effector WAVE2, and we used molecular genetic approaches
specific for WAVE2. Rac1 recruits and activates WAVE2 at locations
where formation of Arp2/3-mediated dendritic actin networks are
required. WAVE2 is one subunit of a pentameric protein complex
that promotes actin nucleation by Arp2/3 complex (Ibarra et al.,
2005; Campellone and Welch, 2010; Derivery and Gautreau, 2010).
In ECs, WAVE2 is known to be important for lamellipodia formation
(Yan et al., 2003; Yamazaki et al., 2005, 2007; Bryce et al., 2013) and
for directed cell migration (Yamazaki et al., 2003).
In this study, we asked how Arp2/3 complex–dependent F-actin
networks contribute to transmigration at each step of the process.
We used perturbation of WAVE2 to provide insight into the role of
Arp2/3 complex during transmigration. We analyzed the dynamics
of living ECs and lymphocytes in a primary-cell culture system using
time-lapse movies, fluorescent fusion proteins, and RNA interference–mediated gene targeting. We found that actin assembly
downstream of WAVE2 in ECs is necessary to engage transmigrating lymphocytes, promote the transcellular route of migration, and
close junctional pores after the lymphocyte moves away. We also
found that WAVE2 is necessary for endothelial monolayer integrity,
which is a critical determinant of overall transendothelial migration,
especially the paracellular route.
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RESULTS
To begin TEM, lymphocytes adhere to the endothelial monolayer
and walk along its apical surface (Supplemental Movie S1 and Figure
1A). Docking structures form on the EC and bind the lymphocyte,
after which the lymphocyte passes through the endothelium via the
paracellular or transcellular route. Supplemental Movie S1 and
Figure 1A show an example of the latter.

Docking structure formation: roles of WAVE2 and Arp2/3
The docking structure is an actin-rich membrane protrusion, which
forms on the surface of the EC as the leukocyte comes in contact
(Barreiro et al., 2002; Carman et al., 2003; Carman and Springer,
2004). The docking structure promotes the physical interaction between the two cells, and it serves as a hub for generation and regulation of signals that drive the subsequent processes of transmigration in both ECs and leukocytes.
We hypothesized that WAVE2 might function in docking structure formation to recruit and activate Arp2/3 complex and induce
the actin assembly that drives protrusions. To test this hypothesis,
we induced docking structures to form on ECs in monolayers using polystyrene beads coated with anti–ICAM-1 instead of lymphocytes. The anti–ICAM-1 on the bead clusters the integrin receptor ICAM-1 on the surface of the EC (Tilghman and Hoover,
2002; van Buul et al., 2007; van Rijssel et al., 2012), mimicking the
action of LFA-1 on the lymphocyte (van Buul et al., 2007). The
docking structures induced by anti–ICAM-1–coated beads resemble those induced by lymphocytes in terms of morphology and
molecular composition. The use of beads allows one to focus exclusively on endogenous components of the EC, avoiding signals
from lymphocytes.
Using immunofluorescence, we observed endogenous Arp2/3
complex, WAVE2, and F-actin on EC docking structures created by
anti–ICAM-1 beads (Figure 1B). ICAM-1 clustered around most
beads, and nearly every ICAM-1–positive bead recruited WAVE2,
Arp2/3 complex, and F-actin, which appeared as rings around the
beads. If beads did not cluster ICAM-1, they did not recruit WAVE2,
Arp2/3 complex, or F-actin. We conclude that ICAM-1 clustering is
necessary and sufficient for recruitment of WAVE2, Arp2/3, complex
and F-actin and that the process of docking structure assembly is
robust.
We assessed the role of WAVE2 in docking structure formation
by depleting WAVE2 with small interfering (siRNA). We chose an
oligonucleotide that decreased WAVE2 protein levels (see Materials
and Methods and Supplemental Figure S1A), and we documented
specificity by rescue with expression of siRNA-resistant WAVE2.
Anti–ICAM-1 beads adhered to WAVE2-depleted cells to a similar
extent as observed for control cells; however, the recruitment of
Arp2/3 complex and F-actin was decreased (Figure 1C). For Arp2/3
complex, 15.5 ± 5.7% (median ± SE of proportion [SEp], N = 40
fields of view [fov]) of beads stained for Arp2/3 complex in WAVE2depleted monolayers, compared with 34.6 ± 7.5% (N = 40 fov) in
control monolayers. For F-actin, 9.0 ± 5.2% (median ± SEp, N = 30
fov) of beads stained for F-actin in WAVE2-depleted monolayers,
compared with 33.7 ± 8.6% (N = 30 fov) in controls (Figure 1D).
The defect in recruitment of F-actin was more prominent than
the defect in recruiting Arp2/3 complex. In control cells, only
3.5 ± 0.6% (mean ± SEp, N = 857 rings) of bead-associated rings
that were positive for Arp2/3 complex did not stain for F-actin. In
contrast, in WAVE2-depleted cells, 33.4 ± 1.9% (N = 619 rings) of
Arp2/3-positive rings did not stain for F-actin. We conclude that
WAVE2 both recruits and activates Arp2/3 complex in the EC in order to induce actin assembly and generate docking structures.
Molecular Biology of the Cell

FIGURE 1: WAVE2 and Arp2/3 complex are important for docking structure formation. (A) Frames from Supplemental
Movie S1 show a lymphocyte undergoing transcellular transmigration through an EC expressing membrane-tagged GFP.
Scale bar, 10 μm. (B) WAVE2, Arp2/3 complex, and F-actin colocalize with rings of ICAM-1 that form around anti–ICAM1–coated beads in contact with ECs after 30 min of incubation. The yz- and xz-projections from three-dimensional (3D)
data sets reveal membrane protrusions extending upward to cup the beads. Scale bar, 20 μm. (C) WAVE2 depletion
decreases the number of bead-associated rings stained for F-actin and Arp2/3 complex. Red arrows indicate rings of
F-actin and Arp2/3 complex around anti-ICAM-1 beads. Scale bar, 50 μm. (D) WAVE2 depletion decreases the number
of beads with associated rings of F-actin and Arp2/3 complex. Beads and positive-stained rings were counted in 10 fov
for three separate experiments (N = 30). Box-and-whisker plots show median, interquartile range, and extremes.

Recruitment of WAVE2 during transmigration
of lymphocytes
After docking structures form, lymphocytes traverse the monolayer
by migrating between cells (paracellular route) or through individual
ECs (transcellular route). For both routes, we observed recruitment
of WAVE2–green fluorescent protein (GFP) in the EC to the site of
transmigration by peripheral blood lymphocytes (PBLs) at distinct
times during the process.
Volume 25 December 15, 2014

For the paracellular route, PBLs migrated over the course of
2–5 min through a pore that formed between two ECs. The pore
often remained open for several minutes after the PBL moved
away from the transmigration site (Figure 2A; asterisk indicates a
persisting pore). WAVE2-GFP did not accumulate at the transmigration site either before or during transmigration (Figure 2A and
Supplemental Movie S2). When the pores closed, if the pore size
was large, ECs produced waves of membrane protrusion as they
WAVE2 regulates transmigration
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FIGURE 2: WAVE2 localization to membrane protrusions that close gaps and form at sites of transcellular pores.
(A) WAVE2 is not recruited to paracellular pores during PBL transmigration. Frames from Supplemental Movie S2.
Asterisk indicates a gap between ECs that persists after transmigration. Scale bar, 3 μm. (B) WAVE2 localizes to
endothelial monolayer gaps that close after lymphocyte transmigration. Frames from Supplemental Movie S3. Asterisks
indicate the gap, which closes after a wave of membrane protrusion. Red arrows indicate membrane waves, where
WAVE2 has accumulated. Scale bar, 3 μm. (C) WAVE2 localizes to docking structures at sites of transcellular migration.
ECs expressing WAVE2-GFP and immunolabeled for ICAM-1. Transmigrating lymphocyte is shown in the DIC image.
The yz- and xz-projections from a 3D data set reveal WAVE2 in membrane protrusions that cup the PBL.

closed the gap. WAVE2-GFP localized at the front of these protrusions, which traveled laterally along the edge of the EC (Figure
2B and Supplemental Movie S3). This dynamic behavior is consistent with the idea that WAVE2 activates Arp2/3 complex and
promotes actin assembly to drive the formation and extension of
membrane protrusions. Small pores sometimes closed rapidly,
4118 | O. L. Mooren et al.

without membrane protrusions, and WAVE2-GFP did not
accumulate.
The transcellular route occurred less frequently in cells expressing WAVE2-GFP, and the degree of inhibition appeared to be proportional to the expression level, so we suspect that the expression
had a dominant negative effect. This effect limited the number of
Molecular Biology of the Cell

FIGURE 3: WAVE2 is important for the transcellular route of lymphocyte transmigration and bulk migration of
lymphocytes across endothelial monolayers. (A) Representative images illustrating the transcellular route (red) and
paracellular route (blue). An endothelial monolayer with transmigrating lymphocytes was stained for ICAM-1, VEcadherin, and F-actin. (B) Quantification of the routes of transmigration by lymphocytes (PBLs). The percentage of total
PBLs that transmigrate by the paracellular or the transcellular route was calculated. Data from experiments on three
separate days are combined and plotted as the mean and SE of proportion (control EC monolayers, N = 3330 PBLs;
WAVE2-knockdown EC monolayers, N = 2167 PBLs). (C) WAVE2-knockdown endothelial monolayers show increased
transendothelial migration by lymphocytes in Transwell assays. Box-and-whisker plots show the median, the interquartile
range, and the extremes of the number of transmigrated cells (N = 14).

transcellular-route events available for movie analysis. As an alternative approach, we used fixed and stained preparations, which allowed us to examine many large fields of view in order to visualize a
sufficient number of events. Fluorescence imaging of anti–ICAM-1
and WAVE2-GFP revealed that WAVE2 was recruited to sites of transcellular TEM in ECs (Figure 2C). Accumulation of WAVE2 was greatest at early stages of transcellular TEM, such as during docking
structure formation, with lesser amounts of WAVE2 observed at later
stages, when PBL migration through the pore was near completion.
In these fixed preparations, identification of pores in the process of
closing is problematic because PBLs often migrate away from the
pore before closure. Therefore we were not able to assess WAVE2
recruitment to sites of transcellular pore closure.

Relative importance of WAVE2 in transcellular
and paracellular routes
To quantitate the effect on WAVE2 depletion on TEM, we first used a
conventional Transwell assay with an endothelial monolayer on the
Volume 25 December 15, 2014

filter separating the upper and lower chambers. We measured the
number of PBLs that migrated from the upper to the lower chamber.
WAVE2 depletion increased the number of PBLs that transmigrated
(Figure 3C). However, the level of variation between experiments was
large with this assay; in some cases, the number of transmigrating
PBLs did not change or decreased. We speculate that this high level
of variance in the assay resulted from variations in the morphology of
the EC monolayer caused by WAVE2 depletion, which was associated with gaps between ECs of variable number and size. The effect
of WAVE2 depletion on EC monolayer morphology is discussed in
more detail later. Expression of siRNA-resistant WAVE2 restored PBL
transmigration to levels similar to that in control endothelial monolayers (Figure 3C).
To address the role of WAVE2 in TEM with a quantitative assay
that would not depend so highly on gaps in the monolayer, we used
a different approach. We fixed TEM preparations and stained them
with anti–VE-cadherin to reveal EC junctions, anti–ICAM-1 to reveal
transendothelial pores, and fluorescent phalloidin to visualize
WAVE2 regulates transmigration
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FIGURE 4: WAVE2 is necessary for limiting gaps and promoting spread-cell morphology in endothelial-cell monolayers.
Images are frames from movies, with control from Supplemental Movie S5 and WAVE2 KD (knockdown) from
Supplemental Movie S4. Scale bar, 100 μm.

migrating PBLs (Figure 3A). This approach allows one to identify
paracellular-route and transcellular-route sites of TEM with certainty.
Paracellular-route sites were defined by PBLs at cell junctions, intercalated between two adjacent ECs, which were not otherwise separated by a gap. Transcellular-route sites were defined by PBLs at
pores in the central region of an EC that was fully spread and in
contact with its neighbors in the monolayer.
Using this approach, we found that depletion of WAVE2 from EC
monolayers decreased the frequency of transcellular TEM events to
51% of the value seen with control EC monolayers; the difference
was highly significant (p < 0.001; Figure 3B). In contrast, the frequency of paracellular TEM events did not change (Figure 3B). Thus
WAVE2 is more important for the transcellular route than the paracellular route. Using these fixed and stained preparations, we measured the dimensions of the pores for transcellular-route events in
the x-y plane and found no difference between control and WAVE2depleted cells. The area of the pores was 37.3 ± 7.7 μm2 (mean ± SE,
N = 12) for control cells and 37.6 ± 6.9 μm2 (N = 8) for WAVE2-depleted cells. We conclude that WAVE2 is important for transcellularroute events to occur, but that when the events do occur, the pores
have a normal size, which is presumably determined by the size of
the migrating cells. For the paracellular route, measuring pore dimensions was confounded by the many gaps between ECs in
WAVE2-depleted monolayers. Finally, we attempted to examine the
dynamics of transcellular pore formation and closure using movies
of living cell movies, but the number of transcellular-route events in
WAVE2-depleted monolayers was too small to allow meaningful
conclusions.

WAVE2 is important for integrity of the endothelial
monolayer
As noted earlier, we observed many intercellular gaps in WAVE2depleted monolayers (Supplemental Movie S4 and Figure 4). Cells
within WAVE2-depleted endothelial monolayers also displayed a
4120 | O. L. Mooren et al.

wide range of individual morphologies. Many were rounded up and
no longer in contact with their neighbors. In movies, these cells were
often blebbing very actively, and they made frequent attempts to
spread back down onto the surface (Supplemental Movie S4). Scoring cells on their morphology, we found that WAVE2-depleted
monolayers had 34.7 ± 23.8% (mean ± SEp, 814 cells, four movies)
rounded-up or blebbing cells, whereas control monolayers had only
0.20% ± 1.99% (968 cells, five movies). This difference was statistically significant, with p < 0.01. Expression of siRNA-resistant WAVE2GFP rescued this phenotype, leading to nearly complete absence of
cells with the rounded-up and blebbing morphology (1.8 ± 0.8%,
402 cells, three movies; Supplemental Movie S6). The p value for
control versus WAVE2 rescue was 0.13.
Movie analysis also revealed that addition of PBLs to control EC
monolayers often caused effects at contacts between EC neighbors,
even when PBLs were located at a distance. These effects consisted
of dynamic ruffling at cell–cell junctions, along with the occasional
formation of small gaps as cells pulled away from one another while
ruffling (Supplemental Movie S5 and Figure 4). When such a gap
appeared, lamellipodial protrusions formed quickly and closed the
gap. In WAVE2-depleted monolayers, the number of gaps was high,
as noted earlier, and there were fewer lamellipodial protrusions that
closed gaps between cells than with control monolayers.
On the basis of these observations of EC monolayers, we hypothesized that WAVE2 depletion might cause defects in the overall
integrity of the endothelial barrier measured by conventional physiological assays. To test this hypothesis, we first measured electrical
resistance across the monolayer (transendothelial resistance [TER];
Figure 5A). WAVE2 depletion caused TER to decrease to levels similar to those caused by chelation of Ca2+, which completely disrupts
cadherin-based cell–cell junctions. Depolymerizing actin with latrunculin A (LatA) also decreased TER by a large amount (Figure 5A) and
created large gaps between ECs (Supplemental Figure S1B), consistent with previous findings (Prasain and Stevens, 2009). Second, we
Molecular Biology of the Cell

FIGURE 5: WAVE2 maintains endothelial monolayer integrity by promoting Arp2/3-based lamellipodial protrusions.
(A) Electrical resistance across monolayers, plotted as a normalized index for TER (see Materials and Methods). Data are
derived from experiments on three or more days, with three or more repetitions on each day. Plotted values are the
mean of all the data points, and error bars are SD (N ≥ 9). (B) Localization of WAVE2 and Arp2/3 complex adjacent to
cell–cell junctions, based on immunofluorescence and fluorescent phalloidin staining of endothelial monolayers. Arrows
indicate localization close to but not coincident with cell junctions. Scale bar, 50 μm. (C) Magnified views of boxed
regions in B. Line scans across cell–cell junctions (blue box) or along junctions (magenta box). Scale bar, 20 μm.
(D) Localization of Arp2/3 complex and WAVE2 at cell–cell junctions formed in response to S1P. Merge, green is
anti-Arp3 or anti-WAVE2; red is VE-cadherin. Top, control; bottom, with S1P added. Scale bar, 50 μm; inset, 20 μm.

measured the permeability of the monolayer to fluorescent dextran,
as an indicator of barrier integrity. Again, EC monolayers depleted
of WAVE2 showed increased permeability compared with control
(Supplemental Figure S1C).
In our experiments, the endothelial monolayers were generally
treated with the proinflammatory molecule TNFα in order to mimic
inflammatory conditions and promote interaction of ECs with PBLs.
Inflammation increases vascular permeability, so we asked whether
TNFα alone would affect barrier integrity in these assays. In control
cells, TER decreased with TNFα treatment (Figure 5A), as expected
(Blum et al., 1997; Nwariaku et al., 2003; Clark et al., 2007). Quantitatively, the effect of TNFα on control monolayers was modest
compared with the large effect of LatA or ethylene glycol tetra
Volume 25 December 15, 2014

acetic acid (EGTA). The effect of WAVE2 depletion was also relatively large, and the addition of TNFα had little to no further effect.
Similar results were seen using the fluorescent dextran permeability assay (Supplemental Figure S1C). Together the results indicate
that WAVE2 depletion results in an essentially complete loss of
endothelial monolayer integrity, in excess of the effect caused by
TNFα.
How might WAVE2 contribute to endothelial monolayer integrity? We reasoned that WAVE2 might localize to cell edges and activate Arp2/3 complex, causing protrusions that initiate contacts
between cells as a prelude to cell–cell junction formation. Lamellipodial protrusions have been implicated in the formation of junctions between epithelial cells (Adams et al., 1996), and lamellipodia
WAVE2 regulates transmigration
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Second, movies revealed that dynamic
lamellar and lamellipodial protrusions
formed along the cell periphery and in the
vicinity of cell–cell junctions (Supplemental
Movie S7). These protrusions contained
WAVE2 at their leading edge (Supplemental Movie S8), which supports the idea that
WAVE2 and Arp2/3 complex drive actin assembly in order to promote formation of
cell junctions and repair gaps between cells.
Consistent with this notion, Taha et al. (2014)
used chemical inhibitors of Arp2/3 complex
to demonstrate that Arp2/3-based lamellipodial protrusions exist and are important
to maintain the endothelial monolayer.
To test this hypothesis further, we increased the number of membrane protrusions by treating endothelial monolayers
with sphingosine-1-phosphate (S1P; Supplemental Figure S2). Ruffling lamellipodia and
lamellar protrusions induced by S1P contained WAVE2 and Arp2/3 complex (Figure
5D). VE-cadherin did not colocalize with
Arp2/3 or WAVE2, indicating that WAVE2
and Arp2/3 complex promote lamellipodial
protrusions before the recruitment of VEcadherin to nascent cell–cell junctions.

Molecular basis for loss of monolayer
integrity on WAVE2 depletion
To investigate the molecular basis for the
loss of monolayer integrity upon depletion of WAVE2, we examined the molecular composition of cell contacts and
cell–cell junctions using immunofluorescence. In control monolayers, VE-cadherin
was predominantly organized in a pattern
typical for mature junctions—continuous
linear structures coinciding with cell–cell
contacts (Figure 6A). In contrast, WAVEdepleted monolayers showed very few
VE-cadherin–positive cell junctions (Figure
FIGURE 6: WAVE2 promotes VE-cadherin expression and maturation of cell–cell junctions.
6A). The number of gaps in the junctions
(A) WAVE2-knockdown monolayers have large gaps between cells, outlined in yellow, and the
intensity of VE-cadherin staining is substantially decreased. Scale bar, 50 μm. (B) Decreased total increased from 3.0 ± 1.0/fov (mean ± SD,
N = 6 fov) in control monolayers to 11.2 ±
VE-cadherin in WAVE2-knockdown monolayers, by immunoblot. (C) Depletion of WAVE2 leads
2.3/fov in WAVE2-knockdown monolayto a change from mature junctions, collinear with the cell edge, to immature junctions
perpendicular to the cell edge, based on staining for VE-cadherin and vinculin. Scale bar, 50 μm. ers. This difference was statistically significant, with p < 0.001.
have been observed during initial formation of cell–cell contacts
We quantitated the level of VE-cadherin at cell junctions in the
between ECs (Hoelzle and Svitkina, 2012). Information about the
immunofluorescence images. In control cells, the level of anti–VEmolecular components that establish junctions or maintain junccadherin fluorescence intensity was 37.9 ± 2.6 arbitrary units (A.U.)
tional integrity of ECs is lacking, but the Arp2/3 complex has been
per junction (median ± SE, N = 126 junctions from 6 fov). In WAVE2implicated in maintaining intact endothelial monolayers (Taha et al.,
depleted cells, for the cell junctions that were present, the anti–VE2014).
cadherin fluorescence intensity was 12.6 ± 3.7 A.U. (median ± SE,
First, we found that WAVE2 was localized near or next to cell
N = 99 junctions from 6 fov). This difference was also highly statistijunctions between ECs but not coincident with junctions in fixed and
cally significant, p < 0.001. In addition, immunoblot analysis restained preparations (Figure 5, B and C). Line scans of fluorescence
vealed that the total level of VE-cadherin expression was decreased
intensity across or along junctions demonstrated that VE-cadherin
in WAVE2-depleted ECs (25.6 ± 0.2%, mean ± SEp, N = 4, p = 0.01)
and WAVE2 were frequently adjacent to, but infrequently coincident
compared with control cells (Figure 6B).
with, each other (Figure 5C). The localization of Arp2/3 complex
In contrast, a similar analysis of the tight junction component
around cell junctions was similar to that of WAVE2 (Figure 5B), conZO-1 showed little to no change upon depletion of WAVE2. Qualisistent with a recent report (Taha et al., 2014).
tatively, by immunofluorescence, ZO-1 was readily observed at
4122 | O. L. Mooren et al.
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persisting junctions in WAVE2-depleted cells, with a pattern and
intensity similar to those of control cells (Supplemental Figure
S3A). Immunoblots revealed only a small decrease of ZO-1 protein
expression; the level in WAVE2-depleted cells was 88% (average
of two experiments) of the level in control cells (Supplemental
Figure S3B).
The junctions that were present in WAVE2-depleted monolayers
appeared to be immature, based on morphology and vinculin content (Figure 6C). Mature cell–cell junctions in control EC monolayers, defined by linear anti–VE-cadherin staining coincident with cell–
cell contacts, displayed a low level of anti-vinculin staining (Figure
6C, top). In control monolayers, vinculin was also present at focal
contacts, which are cell–substrate junctions devoid of VE-cadherin
(Figure 6, C and inset). In WAVE2-depleted monolayers, the VEcadherin at persisting junctions was organized as short, linear structures oriented perpendicular to the cell edge (Figure 6, C and inset),
characteristic of immature cell–cell junctions (Heyraud et al., 2008;
Huveneers et al., 2012). In a quantitative analysis, the number of
mature junctions decreased from 8.7 ± 2.9/fov in control monolayers
to 2.7 ± 0.8/fov in WAVE2-depleted monolayers (mean ± SD, N = 6
fov; p < 0.001).

Functional ability of WAVE2-depleted ECs to form
cell–cell junctions
To investigate further the role of WAVE2 in cell junction formation,
we challenged EC monolayers to assemble junctions by Ca2+ depletion and addition (Figure 7, Supplemental Figure S4, and Table 1).
VE-cadherin–based junctions are lost when Ca2+ is removed, and
they assemble when Ca2+ is added back. We found that depletion
of WAVE2 impaired the efficiency of ECs to form cell junctions in this
assay (Figure 7, Supplemental Figure S4, and Table 1). At all time
points during reassembly, the number of junctions in WAVE2-depleted monolayers was lower than in control monolayers (Figure 7,
Supplemental Figure S4, and Table 1). When junctions re-formed in
the WAVE2-depleted monolayers, the fluorescence intensity of the
tight-junction protein ZO-1 was similar to that in control monolayers
(Figure 7 and Table 1).
Using a complementary quantitative approach, we measured
TER on control and WAVE2-depleted monolayers after calcium depletion and repletion (Figure 7B). WAVE2-depleted monolayers had
a lower initial value for TER, as reported earlier, and they had lower
TER values under all treatment conditions. However, when the TER
values were normalized, the rate at which WAVE2-depleted monolayers recovered their junctions was similar to that for control monolayers. This result is consistent with the observation that ZO-1 levels
are not altered in WAVE2-depleted junctions.
Taken together, our results show that WAVE2 has an important
role in promoting the expression or stability of VE-cadherin and its
recruitment to cell junctions. This role is similar to the role proposed
for WAVE2 in epithelial cells (Bryce et al., 2013). We conclude that
the role of WAVE2 in endothelial monolayer integrity is the formation and maturation of cell–cell junctions.

WAVE2 influences the organization of circumferential
actin and stress fibers
In addition to lamellar protrusions, ECs contain two other F-actin-based structures important for monolayer integrity—stress fibers and circumferential actin structures. These structures contain myosin-II, which is contractile, and they are able to create
tension. In epithelial cells, WAVE2 has been implicated in regulating assembly of circumferential actin (Verma et al., 2012).
In ECs, circumferential actin is less dense and more loosely
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organized; the formation and function of this structure in ECs
have not been studied.
Many WAVE2-depleted cells displayed rounded-up and blebbing morphologies, as noted earlier. These cells did not contain either circumferential F-actin or stress fibers (Supplemental Figure
S5A, red stars). Therefore, for this analysis, we focused on cells that
were in a monolayer and fully spread. We observed that the fluorescence intensity of myosin-II and F-actin in circumferential F-actin fibers in such cells was increased in WAVE2-depleted endothelial
monolayers compared with control-cell monolayers (Figure 8, A and
B). This finding suggests that increased tension from circumferential
actin causes WAVE2-depleted cells to round up.
If this hypothesis is correct, then one would expect increased
tension to result in decreased area in well-spread cells in WAVE2depleted monolayers. As expected, the area of well-spread cells in
WAVE2-knockdown monolayers was smaller (1980.8 ± 92.2 μm2,
mean ± SE, N = 99) than that of control cells (2430.2 ± 116.7 μm2,
N = 71). The difference was statistically significant, with p = 0.003.
However, we found that the total levels of F-actin and myosin-II
were not affected by WAVE2 depletion. The total level of myosin-IIA
fluorescence staining per cell was similar for WAVE2-knockdown
and control monolayers, with intensity values of 6.0 × 106 ± 3.3 × 106
A.U. (median ± SD, N = 99 cells) and 5.6 × 106 ± 4.1 × 106 A.U.
(N = 71 cells), respectively (p = 0.9). The level of F-actin, determined
by immunoblots of detergent-resistant cytoskeletons (see Materials
and Methods), was also similar in WAVE2-knockdown and control
cells (Supplemental Figure S5B).
Considering these results together, we suggest that depletion of
WAVE2 shifts F-actin and myosin-II into the circumferential F-actin
fiber pool, which increases tension. Increased tension, in turn, decreases cell size and increases the likelihood that cell lose contact
and round up.
Previous studies of endothelial monolayers found that inflammatory conditions lead to loss of monolayer integrity, in association
with decreased circumferential actin and increased stress fibers
(Stolpen et al., 1986; Blum et al., 1997; Clark et al., 2007). First, we
confirmed these results in our preparations; control-cell monolayers
treated with TNFα showed loss of circumferential actin with increased stress fibers (Figure 8C, left, arrows, and right, arrows). Next
we observed that depletion of WAVE2 prevented these TNFαinduced changes. Circumferential actin staining was increased, not
decreased, and stress fibers did not increase (Figure 8C). Thus the
inflammatory effects of TNFα require the presence of WAVE2, presumably due to effects on dynamic actin assembly.
Overall our results show that WAVE2 enhances the assembly
and influences the organization of circumferential actin fibers. We
also conclude that WAVE2 is important for the reorganization of
fibers under inflammatory conditions, most likely by an indirect
mechanism.

DISCUSSION
The most important finding of our study is that ECs use WAVE2 to
create Arp2/3-based actin filament networks necessary for lymphocyte transmigration. EC WAVE2 appears to activate Arp2/3 complex
and thereby promote actin assembly at the docking structures that
bind lymphocytes to the EC. We also found a role for WAVE2 and
Arp2/3 complex in generating lamellipodial protrusions that contribute to the integrity of EC monolayers by closing gaps caused by
inflammatory conditions or transmigrating lymphocytes. Our results
provide insight into the tissue-level mechanisms by which the vascular endothelium maintains a dynamic barrier and selectively orchestrates transmigration during inflammation.
WAVE2 regulates transmigration
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FIGURE 7: WAVE2 is important for junction assembly after calcium depletion and addition. (A) Calcium was removed
from the medium with EGTA to disassemble cadherin-based junctions and then replaced to induce reassembly. Images
are representative of 5 fov from each of three samples. Scale bar, 50 μm. (B) WAVE2 knockdown causes a defect in
junctional assembly after calcium addition, based on TER measurements over time. (C) Time course of junction assembly
revealed by the TER data from B normalized for control and WAVE2-depleted monolayers. The time courses are similar,
suggesting that junctions recover at a normal rate.

Endothelial WAVE2 controls transmigration of lymphocytes
In an early step in transmigration, docking structures form on the
surface of ECs; membrane protrusions formed by dynamic actin
assembly reach up and surround the lymphocyte (Barreiro et al.,
2002; Carman and Springer, 2004; van Buul et al., 2007). Here we
found that WAVE2 and Arp2/3 complex are recruited to these
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membranes and are necessary to form the protrusions and docking structures.
WAVE2 has a critical role in docking structure formation, which
may overlap and synergize with roles of other regulators of Arp2/3
complex. Dendritic actin network assembly is a multistep process,
and other proteins likely assist in recruiting and activating Arp2/3
Molecular Biology of the Cell

Ca2+ addition
Parameter

Condition

Junctions/fov
ZO-1 intensity (A.U.)

No treatment

EGTA

Control

24.8 ± 1.8

6.4 ± 1.6

KD

14.7 ± 2.9*

2.8 ± 0.8

Control

40.5 ± 0.9

21.5 ± 1.4

KD

55.7 ± 1.5*

28.4 ± 2.5*

30 min

60 min

12.8 ± 2.7

45.3 ± 3.1

42.9 ± 2.0

14.3 ± 1.7*

20.5 ± 1.3*

42.0 ± 2.1

40.7 ± 1.4

73.1 ± 1.7

30.5 ± 3.5

42.2 ± 2.3

66.0 ± 2.7

3.9 ± 1.3*

90 min

Standard error is reported for the number of junctions per field of view (fov) and for the ZO-1 fluorescence intensity level in arbitrary units. KD is WAVE2 knockdown.
Asterisk indicates statistical significance for KD compared with control with p < 0.001.

TABLE 1: WAVE2 is necessary for formation of new junctions.

complex. We found that WAVE2 depletion caused a larger defect in
the recruitment of F-actin than Arp2/3 complex to docking structures. We detected N-WASP and cortactin in docking structures,
confirming previous findings for cortactin (Tilghman and Hoover,
2002; Yang et al., 2006a). Thus, whereas other regulators may contribute to recruitment of Arp2/3 complex, WAVE2 appears to be
critical for its activation. In other settings, multiple Arp2/3 regulators
play complementary and synergistic roles to bind and activate
Arp2/3 complex for actin nucleation (Padrick et al., 2011; Ti et al.,
2011; Helgeson and Nolen, 2013). Many Arp2/3 regulators possess
multiple domains for interactions with other proteins, which may
amplify signals and regulate the assembly of the docking structure.
A second step in lymphocyte transmigration is creation of a
pore used by the lymphocyte to cross the endothelial monolayer.
A pore can be created by weakening a junction between two ECs
(the “paracellular” pathway) or by forming a pore through the interior of one EC (the “transcellular” pathway). We discovered that
WAVE2 and Arp2/3 complex are critical for the transcellular pathway. As a transcellular pore develops, the EC controls the size of
the pore and provides it with structural stability to preserve cell
viability and integrity. We envision that Arp2/3-based filament networks surround the transcellular pore and maintain its size and stability while the lymphocyte is transmigrating. In addition, many
membrane-remodeling events occur during transcellular pore
formation, and Arp2/3 complex and its activators may be important for those events.
A third step in transmigration is closure of the pore, returning the
endothelial monolayer to its original state. We found that, after the
lymphocyte transmigrates, lamellipodial protrusions form and fill
the pores, allowing ECs to recreate contacts and cadherin-based
cell junctions with their neighbors. Actin assembly induced by
WAVE2 and Arp2/3 complex drives these lamellipodial protrusions.
How cells and layers of cells close gaps, including ones created
by artificially induced wounds, has been studied in a variety of cell
and tissue systems. In some cases, closure of the wound involves
lamellipodial or filopodial protrusions that extend from cells on the
edge of the wound to create new cell–cell contacts (Bement et al.,
1993; Jacinto et al., 2001; Mattila and Lappalainen, 2008). In epithelial cell layers and in single egg cells, wounds are often closed by a
contractile purse string of F-actin and myosin-II (Martin and Lewis,
1992; Bement et al., 1993, 1999; Sonnemann and Bement, 2011).
Here, in ECs, we found that lamellipodial wave-like protrusions of
the plasma membrane closed the gaps between cells, consistent
with results for closing wounds in other endothelial systems
(Martinelli et al., 2013; Taha et al., 2014). Martinelli et al. (2013) observed that EC lamellipodia closing transcellular wounds were located in a ventral position. We did not observe ventral lamellipodia
in our experiments; however, one can imagine that WAVE2 might
also promote the formation and movement of those structures.
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WAVE2 promotes and maintains EC junctions by modulating
actomyosin organization
We also found that WAVE2 was important for the architecture of
actin–myosin structures in ECs, including circumferential F-actin and
stress fibers. Resting ECs in monolayers have a loose circumferential
band of F-actin and myosin-II near the cell edge, which presumably
helps maintain cell–cell junctions and monolayer integrity. In epithelial cells, cell–cell junctions are associated with a denser band of
dynamic actin filaments, along with a cortical Arp2/3-based filament
network (Ivanov and Naydenov, 2013).
Epithelial cells do not have lamellipodia at mature junctions, in
contrast to our findings here with ECs. In epithelial cells, WAVE2
localizes to mature cell junctions, where it regulates actin assembly
(Yamazaki et al., 2007; Verma et al., 2012). In our studies here of
ECs, WAVE2 and Arp2/3 did not localize to stable cell–cell junctions. Whereas WAVE2 and Arp2/3 complex did localize to the cell
periphery and to the locations of cell–cell contacts, their localization
and activity were restricted to junctions that were actively assembling, with lamellipodial membrane protrusions.
Tension is an important parameter that determines the strength of
the endothelial barrier, one that is highly regulated under resting and
inflammatory conditions. For epithelial cells, WAVE2 regulates cell
tension in monolayers by affecting the level of contractile myosin-II,
the amount of F-actin, and the organization of cortical actin and actin
fibers at cell junctions (Verma et al., 2012). Our results here with EC
monolayers also suggest that WAVE2 contributes to cell tension by
influencing actomyosin organization under both basal and inflammatory conditions. The mechanism for how WAVE2 and Arp2/3-based
networks contribute to actin fiber organization remains unclear; we
speculate that branched filaments from Arp2/3-based networks incorporate into circumferential filament bundles or stress fibers.

MATERIALS AND METHODS
Cells
Human dermal microvascular ECs from neonates were purchased
from Lonza (Basel, Switzerland), maintained in EGM-2MV media
(Lonza), and used between passages 2 and 12. PBLs were collected
from healthy blood donors (Leukopak; Hemerica, West Warwick, RI)
and treated as previously described (Carman and Springer, 2004;
Cernuda-Morollon et al., 2010). PBLs were maintained in culture in
RPMI with 10% fetal bovine serum (FBS) and interleukin-2 (10 U/ml)
for 5–10 d before use in experiments.

Reagents and antibodies
Treatment of cells with TNFα (Life Technologies, Frederick, MD) consisted of overnight incubation at 20 ng/ml. S1P (Sigma-Aldrich, St.
Louis, MO) treatment was at 0.5 μM for 5 min. Anti–ICAM-1 antibodies included mouse BBIG-I1 from R&D Systems (Minneapolis, MN)
and rabbit H-108 from Santa Cruz Biotechnology (Dallas, TX).
WAVE2 regulates transmigration
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FIGURE 8: WAVE2 controls the organization of actin-myosin fibers in ECs. Areas with well-spread cells were selected to
reveal circumferential actin–myosin rings and stress fibers. (A) Control and WAVE2-knockdown endothelial monolayers
stained for F-actin and myosin-IIA. Scale bar, 50 μm. (B) Line scans across representative actin–myosin rings in control
and WAVE2-depleted cells. (C) WAVE2 influences changes in circumferential actin rings and stress fibers induced by
TNFα. Arrows indicate the circumferential to linear change in actin organization that results from TNFα. When WAVE2 is
depleted, circumferential actin is increased and stress fibers are decreased with and without TNFα. Scale bar, 50 μm.

Antibodies to VE-cadherin included a monoclonal mouse anti–human CD144 antibody (clone 55-7H1; BD Biosciences, San Jose, CA)
and a polyclonal rabbit anti–human VE-cadherin antibody (#2158;
Cell Signaling, Danvers, MA). Anti-GFP was a rabbit polyclonal
(ab6556; Abcam, Cambridge, MA). Anti-Arp3 was either a mouse
anti–human monoclonal (FMS338; Sigma-Aldrich, St. Louis, MO) or
a rabbit anti–bovine polyclonal (Welch et al., 1997)). Rabbit anti–
human WAVE-2 monoclonal antibody (D2C8, #3659) was from Cell
Signaling. Mouse anti–human ZO-1 monoclonal antibody (ZO1
-1A12) was from Invitrogen (Camarillo, CA). Mouse anti–human
glyceraldehyde-3-phosphate dehydrogenase monoclonal antibody
4126 | O. L. Mooren et al.

(6C5) was from Abcam. Mouse anti–human vinculin monoclonal antibody (hVIN-1) was from Sigma-Aldrich. Rabbit anti–nonmuscle
myosin heavy chain II-A polyclonal antibody (PRB-440P) was from
Covance (Emeryville, CA). Secondary antibodies and phalloidin,
fluorescently conjugated with Alexa dyes, were obtained from
Molecular Probes (Life Technologies, Eugene, OR).

DNA and siRNAs
Human cDNA encoding WAVE2 fused at its C-terminus to GFP was
a gift from Tadaomi Takenawa (Kobe University, Kobe, Japan). The
WAVE2 coding region from that plasmid was subcloned into the
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pBOB-GFP lentiviral vector (gift of George Bloom, University of Virginia, Charlottesville, VA). Lentivirus carrying the pBOB-GFP-WAVE2
plasmid were generated as described later. For expression of membrane-tagged GFP, plasmid 14757 was obtained from Addgene
(Matsuda and Cepko, 2007).
siRNAs were obtained from Dharmacon (Thermo Scientific, Pittsburgh, PA). First, a pool of four siRNAs targeting human WAVE2
(ON-TARGETplus SMARTpools for WASF2) was tested to assess
phenotype. Next individual siRNAs from that pool were tested. The
oligonucleotide (GGAUUUGGGUCUCCAGGGA) that produced the
largest decrease in WAVE2 expression (∼80–85%, based on immunoblots; Supplemental Figure S1A) was chosen for subsequent studies.
Off-target siRNA effects were excluded by demonstration of rescue
of WAVE2-knockdown phenotypes by expression of WAVE2 from
siRNA-resistant full-length cDNA constructs with six codon-neutral
point mutations (GGcTTcGGcTCaCCgGGaA). Cells were transfected
using Lipofectamine RNAiMAX transfection reagent (Invitrogen).

Lentivirus production
Human WAVE2-GFP and plain GFP, as a control, were expressed
in HDMVECs by lentiviral transduction. Lentivirus was produced
by transfecting a 6-cm dish of HEK293T cells with 4.8 μg of DNA,
including pBOB-GFP (2 μg), pMDL/PRRE (1.45 μg), pVSVG
(0.8 μg), and pRSV-rev (0.55 μg). Transfection was performed with
TransIT-LT1 (Mirus, Madison, WI) in low-antibiotic HEK293T culture medium (DMEM, 10% FBS, 0.1× penicillin/streptomycin [pen/
strep]). The medium was changed on the next day to DMEM with
30% FBS and 1× pen/strep. Media containing virus was collected
48 h posttransfection and concentrated by ultracentrifugation.
For viral transduction, HDMVEC cells were incubated with lentivirus overnight in the presence of 10 μg/ml protamine sulfate.

Permeability assays
Permeability assays were performed by adding 40-kDa fluorescein
isothiocyanate–dextran (gift from Robyn Klein, Washington University, St. Louis, MO) to the top chamber of a Transwell device. After 1 h,
fluorescence was measure in medium collected from the bottom chamber. The permeability coefficient (PC) was calculated as follows:
PC =

V
C
× R
SA × C D T

In this equation, V is the volume of the receiving chamber, SA is the
surface area, CD is the concentration of tracer in the donor chamber
at time zero, and CR is the concentration of tracer in the receiving
chamber at time T. CR was calculated from fluorescence intensity.
Permeability index was calculated by normalizing PC values on a
scale from 0 to 1, with 0 defined as the value for control monolayers
and 1 as the value for the Transwell membrane alone without ECs.

Germany) using a 40×/1.2 numerical aperture (NA) water immersion
objective. Wide-field fluorescence images were collected using an
inverted microscope (Olympus IX-81; Olympus, Center Valley, PA)
with a 40×/0.75 NA objective, a Hg-lamp light source and a Hamamatsu electron-multiplying charge-coupled device video camera
(Hamamatsu, Bridgewater, NJ).
Live-cell movies, with fluorescence and differential interference
contrast (DIC) optics, were collected on a Zeiss 510 LSM equipped
with a CO2- and temperature-controlled stage insert (Tokai Hit,
Shizuoka-ken, Japan). Movies were also collected on an inverted
microscope (Olympus IX73) equipped with a CoolSnap HQ video
camera (Photometrics, Tucson, AZ) and the same stage insert.
Movies were collected with a 10×/0.25 NA phase objective or a
40×/0.75 NA objective.

Transwell assay for transmigration
HDMVECs were seeded at 3 × 104 cells/well in a 24-well Transwell
dish (3-μm pore size; Corning, Fisher Scientific). Inserts were coated
with 15 μg/ml fibronectin (Sigma-Aldrich) before seeding. Cells were
cultured on Transwell for 48 h before experiments, with 20 ng/ml
TNFα added for 4 h before addition of PBLs.
At time zero, TNFα-containing medium was removed from the
Transwell chambers, 1.5 × 105 PBLs in regular HDMVEC medium
were added to the top chamber, and medium with SDF1α (30 ng/
ml) was added to the bottom chamber. PBLs were allowed to migrate across the Transwell at 37°C for 1 h. Cells were collected from
the bottom chamber and counted using a hemocytometer.

Docking structure formation and staining
Anti-ICAM antibodies (rabbit or mouse, described earlier) were
coupled to polystyrene beads (10 μm; Polysciences, Warrington,
PA) per the manufacturer’s recommendations. Anti-ICAM–coated
beads were incubated with TNFα-treated HDMVECs (20 ng/ml
TNFα, overnight) for 30 min at 37°C. To visualize the localization of
F-actin and Arp2/3 complex to the anti-ICAM bead and docking
structure, we stained cells with fluorescent phalloidin and antibodies, as described earlier. A z-series of images was collected with a
laser-scanning confocal microscope (Zeiss LSM510). The images
were scored for the presence of rings of F-actin or Arp2/3 complex
around the beads.
In control experiments, beads coated with nonspecific anti–
mouse or anti–rabbit immunoglobulin G did not adhere to TNFαtreated endothelial monolayers. In addition, the number of beads
adhering to the cells and the number of docking structures were
much less if ECs were not treated with TNFα, which increases the
level of cell-surface ICAM-1 (Pober et al., 1986; Dustin and Springer,
1988; Detmar et al., 1990; Yang et al., 2005).

Transendothelial resistance
Staining of cells with fluorescent antibodies and phalloidin
In most cases, cells were fixed with paraformaldehyde, permeabilized, and incubated with primary and secondary antibodies as described (Mooren et al., 2009). In some cases, the fixative was trichloroacetic acid (TCA); cells were treated with ice-cold 10% TCA for
15 min. Fluorescent phalloidin was added to secondary antibody
solution in some cases. Coverslips were mounted in Vectashield
(H1000; Vector Laboratories, Burlingame, CA) or ProLong Gold (Life
Technologies, Grand Island, NY).

HDMVECs were plated on fibronectin-coated Transwells as described and grown to confluence. Resistance across the Transwell
filter was measured with an EVOM-2 m and an Endohm-6 electrode
adapter (World Precision Instruments, Sarasota, FL). TER was calculated by subtracting the resistance of a blank well from that of the
sample well and multiplying that difference by the surface area of
the filter. The TER index was calculated by normalizing the TER values on a scale from 0 to 1, with 0 as the value for LatA treatment and
1 as the value for control monolayers.

Light microscopy

Quantitation of the route of transmigration

For immunofluorescence, a set of z-stack images was collected with
a laser-scanning confocal microscope (Zeiss 510 LSM; Zeiss, Jena,

HDMVECs were plated to confluence on fibronectin-coated polyacrylamide (PA) gels (Onken, Mooren, Mukherjee, Shahan, Li, and
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Cooper, unpublished data. Coverslips were functionalized by
silanization for 3 min using aminosilane (Sigma-Aldrich). Next
the coverslips were treated for 30 min with 0.5% glutaraldehyde
(Sigma-Aldrich). PA gels were made by using a mixture of 7% acrylamide and 3% (3-acrylamidopropyl) trimethylammonium chloride
(Sigma-Aldrich) in phosphate-buffered saline. To vary the polymer
stiffness, 0.4% bis-acrylamide was added. Next 0.1% APS (ammonium persulfate; Sigma-Aldrich) and 0.1% TEMED (N,N,N′,N′tetramethylethylenediamine; Sigma-Aldrich) were added to the
mixture to initiate polymerization. This gel mixture was placed as a
large droplet on the functionalized coverslip. A nonfunctionalized
glass coverslip was placed on top of the gel mixture to sandwich the
liquid between the two coverslips to create a thin, flat gel. PA gels
were polymerized for ∼30 min before coating with fibronectin. Addition of 0.4% bis-acrylamide resulted in a ∼50-kPa stiffness (Tse and
Engler, 2010), which produced the highest number of transcellularroute migration events compared with glass and PA gels of higher
or lower stiffness (Onken et al., unpublished data).
PBLs were added to confluent EC monolayers on PA gels for
15 min before fixation. Samples were processed for immunofluorescence and stained for VE-cadherin, ICAM-1, and F-actin in order to reveal the route of PBL transmigration. Events were
counted by a variety of methods, but at least 15 fields of view
were counted per dish. The percentage of cells was calculated by
the total number of events divided by the total number of PBLs
counted. The p values were calculated using a 2 × 2 contingency
table and Fisher’s exact test.

Quantitation of F-actin, myosin-IIA, and VE-cadherin
F-actin cytoskeletons were prepared from HDMVEC cells by treatment with 0.01% saponin and 0.07 μM phalloidin in 60 mM 1,4-piperazinediethanesulfonic acid, 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10 mM EGTA, and 2 mM MgCl2, pH 6.9, for
3 min at 37°C. Cells were washed twice, and then hot 1× SDS sample buffer (50 mM Tris/HCl, pH 6.8, 4% SDS, 0.1% bromophenol
blue, 10% glycerol, 5% β-mercaptoethanol) was added. SDS–PAGE
and anti-actin immunoblots were performed. For myosin-IIA, corrected total cell fluorescence was calculated from immunofluorescence images as described (Burgess et al., 2010). For VE-cadherin,
line scans with a width of 7 μm were prepared from representative
portions of immunofluorescence images with ImageJ (National Institutes of Health, Bethesda, MD).
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